Who Paid My Doc
Shabbar Danish
Neurological Surgery Neptune, NJ Medical Doctor
NPI 1881757268 CMS profile 357674
19 Davis Avenue, Hope Tower 4Th Fl., Neptune, NJ 07753
General payments
$266,819
Research payments
$1,362
Ownership & investment interest
$1,191,012
Research they led as principal investigator
$1,703
Through program year 2025, Shabbar Danish of Neptune, NJ is reported in the CMS Open Payments database as having received $266,819 across 439 general payments and $1,362 in research payments paid to them. Separately, studies naming them as principal investigator received $1,703 in research payments, paid to institutions rather than to them. They also declared ownership or investment interests valued at $1,191,012 across 7 holdings.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.
General payments for this record sit in the 95th percentile of Neurological Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
15 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $35,953 | 88 | |
| 2024 | General | $80,426 | 80 | |
| 2023 | General | $31,553 | 52 | |
| 2022 | General | $29,423 | 67 | |
| 2021 | General | $13,214 | 38 | |
| 2020 | General | $27,630 | 45 | |
| 2020 | Research | $1,362 | 1 | |
| 2019 | General | $48,619 | 69 | |
| 2025 | Ownership | $219,298 | 1 | |
| 2024 | Ownership | $219,600 | 1 | |
| 2023 | Ownership | $214,866 | 1 | |
| 2022 | Ownership | $165,072 | 1 | |
| 2021 | Ownership | $221,390 | 1 | |
| 2020 | Ownership | $150,785 | 1 | |
| 2019 | Ownership | $0 | 1 |
Beside peers
- Shabbar Danish
- Neurological Surgery median
- Middle half of Neurological Surgery
- National median
In program year 2025, general payments to Shabbar Danish were reported at $35,953. Among 5,467 Neurological Surgery profiles paid that year, the median was $596 and the middle half received between $159 and $3,102.
Show as a table
| Year | Shabbar Danish | Neurological Surgery median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $48,619 | $582 | $138–$3,006 | $163 |
| 2020 | $27,630 | $294 | $76–$2,174 | $114 |
| 2021 | $13,214 | $387 | $105–$2,432 | $132 |
| 2022 | $29,423 | $542 | $139–$2,989 | $149 |
| 2023 | $31,553 | $534 | $145–$2,697 | $160 |
| 2024 | $80,426 | $574 | $155–$3,046 | $164 |
| 2025 | $35,953 | $596 | $159–$3,102 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Prescribing to Medicare patients
Part D · data year 2024 · 2 drugsPart D claims
26
Drug cost
$160
Branded share of claims
57.7%
| Drug | Type | Relative to their largest | Claims | Drug cost |
|---|---|---|---|---|
| Acetaminophen-Codeine Acetaminophen With Codeine | Brand | 15 | $96 | |
| Cephalexin | Generic | 11 | $64 |
Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,779 Part D prescribers listed as Neurosurgery; they describe a distribution and say nothing about conduct.
Billing to Medicare
Part B · data year 2024 · 71 billing codesPaid by Medicare
$177,960
Medicare patients
215
Services billed
467
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 61% | |
| Diabetes | 42% | |
| Ischemic heart disease | 38% | |
| Depression | 35% | |
| Chronic kidney disease | 26% | |
| Cancer | 24% | |
| Heart failure | 18% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
440 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neurological Surgery in New Jersey
Robert Heary
Neurological Surgery · Newark, NJ
Harshpal Singh
Neurological Surgery · Hackensack, NJ
Ira Goldstein
Neurological Surgery · Montclair, NJ
Karthik Madhavan
Neurological Surgery · Cherry Hill, NJ
Simon Salerno
Neurological Surgery · Wall Township, NJ
Adam Lipson
Neurological Surgery · Union, NJ
Related records
Neurological Surgery in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Neurological Surgery
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.